clinical trail of kana kazhichal

A Clinical Evaluation of Mookurattai Ennai a siddha drug for Bacillary Dysentery in children on open clinical study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/02/007952

Enrollment

Registered

2017-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with symptoms of increased frequency of stool with mucus atleast 3-4 times per day fever abdominal pain

Interventions

Intervention1: MOOKURATTAI ENNAI internal medicine: MOOKURATTAI ENNAI internal medicine 1.6 ml per oral od for 3 days Control Intervention1: Na: Na

Eligibility

Inclusion criteria

Inclusion criteria: Frequent passing of stools with mucus at least 3 or 4 times per day Fever Abdominal pain

Exclusion criteria

Exclusion criteria: High fever Severe dehydration Extra intestinal complication Chronic diarrhoea

Design outcomes

Primary

Measure	Time frame
Good-reduced all clinical symptoms Moderate-reduced some clinical symptoms Poor-No improvement or change in clinical symptomsTimepoint: 3 days	—

Secondary

Measure	Time frame
It is mainly assessed by therapeutic efficacy of the trial drugs Timepoint: 1 month	—

Countries

India

Contacts

Public ContactDr K Suresh

National Institute of Siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026